NEWS

GENOME & COMPANY CHOOSES LUINA BIO TO SUPPLY INNOVATIVE DRUG PRODUCT FOR CLINICAL TRIALS PROGRAMME

Brisbane, Queensland, Australia – 31 July 2018 – – Luina Bio, a leading biopharmaceutical manufacturing company in Australia, today announced it will develop and produce an innovative bacterial drug product for Genome & Company to support its clinical trials programme. The relationship signals Luina Bio’s first foray into Asia and further establishes its global leadership in the current Good Manufacturing Practise for microbiome projects.

 

기사 전문보기

No comments
LIST

    댓글은 닫혔습니다.

위로이동